⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 9, 2026The LancetOpen Access

Adult obesity and risk of severe infections: a multicohort study with global burden estimates

Solja T. Nyberg Philipp Frank Sara Ahmadi-Abhari Jaana Pentti Jussi Vahtera Jenni Ervasti Sakari Suominen Timo E Strandberg Pyry N. Sipilä Seppo Meri N Sattar Mika Kivimäki

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Wellcome Trust, Medical Research Council, and Research Council of Finland.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nyberg et al. (2026) studied this question.

synapsesocial.com/papers/69ea30f93230fc0e6cccf6bb https://doi.org/10.1016/s0140-6736(25)02474-2

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Retrospective Study · 2025 · 1,129 citations
2Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021Original Research · 2025 · 473 citations
3Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021Original Research · 2024 · 1,025 citations
4Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort studyCohort Study · 2022 · 631 citations
5Body mass index and infection risks in people with and without type 2 diabetes: A cohort study using electronic health recordscohort · 2025 · 3 citations

More related papers

The impact of obesity on immune response to infection: Plausible mechanisms and outcomes2021
Triple threat: how diabetes results in worsened bacterial infections2024
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 20212024

More from The Lancet

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trialThu,
Department of ErrorThu,